• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Geisinger Appoints Jaewon Ryu, MD, as President and Chief Executive Officer

Article

Geisinger announced that its Board of Directors has appointed Jaewon Ryu, MD, JD, as president and chief executive officer. Dr. Ryu, who has served as interim president and CEO since November 2018 and executive vice president and chief medical officer since September 2016, becomes the seventh chief executive officer in Geisinger’s 104-year history. He succeeds David T. Feinberg, M.D., MBA, who left Geisinger earlier this year to assume a leadership role at Google.

Former Chief Medical Officer and Geisinger’s interim CEO assumes new role effective July 1

DANVILLE, Pa. — Geisinger today announced that its Board of Directors has appointed Jaewon Ryu, MD, JD, as president and chief executive officer. Dr. Ryu, who has served as interim president and CEO since November 2018 and executive vice president and chief medical officer since September 2016, becomes the seventh chief executive officer in Geisinger’s 104-year history. He succeeds David T. Feinberg, MD, MBA, who left Geisinger earlier this year to assume a leadership role at Google.

“On behalf of the Geisinger Board of Directors, I am thrilled to appoint Jaewon Ryu as Geisinger’s next president and CEO,” Board Chairman John C. Bravman, PhD, said, “We conducted an exhaustive national search that included some of the brightest, most accomplished health care leaders in the country. Dr. Ryu has a strong understanding of the Geisinger organization, in addition to broad clinical and management expertise. In his recent roles as Chief Medical Officer and as interim CEO, Dr. Ryu has fostered a culture at Geisinger that pushes us to bring the most innovative care to our patients and communities. He has driven tremendous progress here, and we are confident he will continue to do an excellent job leading our path forward.”

“I am honored by this appointment and feel blessed to lead an organization that is making better health easier for our patients, members and communities,” Dr. Ryu said. “The country looks to Geisinger as a leader in bringing world-class care and coverage to everyone we serve. I am incredibly proud of the progress we are driving in expanding our value-based care model. Geisinger has a bright future ahead, and I am committed to building upon our legacy working with our dedicated and talented physicians and staff.”

Read the full press release.

Related Videos
Dr Padma Sripada, Columbia Internal Medicine
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Joshua K. Sabari, MD< NYU Langone Perlmutter Cancer Center
dr marisa mcginley
Leslie Busby, MD, Rocky Mountain Cancer Centers
Camilla Levister
dr daniel ontaneda
Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.